Member Info for Yorkshirepragma

Most USA announcements as you indicate. Set the alarm .

CV19...users desperate for quick testing.

Thats Times .. apologies not armed

Cripes! What a wheeze of a share at this jolly price !sorry couldn’t resist.. lockdownitis ..
On a serious note armed today NHS deputy chief calls for more testing.., and ?

Cytiva treatment partner? Same tech to some part
https://www.cytivalifesciences.com/en/us/news-center/covid19-vaccine-candidate-from-japan-10001

RK, Just to add ‘ balance’,I happened to find my old acquisition notes from a long time ago....only main theme was ‘ find the grand negatives’ . If you put where we are on the table today, although all’s in development ,there don’t seem to be any’ post proving’ concerns. It’s all go for me. It should just motor up and be bought I suspect. MM suggests sooner rather than later? My sense in current climate that’s highly likely..
GLA

RD, All on the net. Their CEO, is a Biotech leader. Will take a look and prob. buy.

https://www.molecularpartners.com/molecular-partners-initiates-anti-covid-19-therapeutic-program-leveraging-multi-target-binding-of-darpin-proteins-to-neutralize-sars-cov-2-virus/

& mass specs. Are the workhorse of the lab. Everybody’s got one..simples..

RK, Wholeheartely endorse your last para.
Cheers
GLA

I think you answered your own question there....great new tech. Well understood and being applied by experts...

Comment :- Possibly only 6 months immunity was seen from Corovid virus antibody behaviour. Not a great message for the future of societies ,if scientifically Re- confirmed.
However it adds considerably to need for swift efficient testing to allow ‘normality ‘ to return.

RD, I would tend to agree. A co of Two phases..
.Firstly ...Covid base should tie 3-4bn potentially.
Followed by ? 5+?...From a successful approach in the therapeutic areas underway.
Serendipity.?
And superb technology...

There’s been a past reasoned discussion on takeover at some point of this Biotech leader. MMc indicated it would avoid making a decision to sell. I wonder what the company values for this might be? ...it was stargazing to some extent, but now seems to be an emerging poss?

Additional,point...( as an old lab techie) Instrumentation such as this also needs calibration, QA etc ...whereas LFD inherent quality in manufacture ....much an easier proposition for airports/ ports/ offices etc

Still a test which requires a competent operator....some reservations in company notes on prep.. Am sure it’ll have a place, but suspect won’t better a lateral flow device ( dip and look for lines ) approach.
All have a space here, market enormous as has been obviously said.
GLA

https://www.huffingtonpost.co.uk/entry/coronavirus-tests-false-negatives_uk_5eabff89c5b65156135bff75?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvLnVrLw&guce_referrer_sig=AQAAANMNEO5HMoWyq6_2klqfJEr9LUiJfByJgUjQSB5moLsEvFE_XaQPnrP3QVUDdqh8tqEmPZGkswVP55aAIvUHFTPiBfvQmbBD4bSJkh07k7PN1q-CbXExysGaVOXQ6buKXH0tP3b-AnQdTFvkMLka-9mLfHClFSDllZLOEMuLCJGS

Need for saliva test!

Comment...just had need to do swab test( tonsils and nose). Really hard test to practically undertake...there must be many who can’t/ won’t do this.
Roll on saliva test...it will make a tremendous practical difference!

Extraordinary move up from distributor announcement ,albeit for part of the action. Just shows what PR does..
Comment re Amazon, would be great...tha’never knows’ as they say int ‘North
GLA

BooHoo...market cap 3.6bn....good partner.
More flexibility and celerity to market, than the ‘normal’ bigger players likely.
Not surprised Alastair chose this invested partner, will achieve a lot more for Avacta am sure, and no ‘messing about ‘,en route.
GLA